Negotiating with pharma: lessons from the EU COVID-19 vaccine negotiations
EPHA #A2MDialogues

18 May 2021

12:00-13:00 CEST


Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe. 

A one-on-one interview with Clemens Auer, Special Envoy for Health, Austrian Ministry of Health




Clemens Auer 

Special Envoy for Health

Austrian Ministry of Health


Interviewed by

Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines

European Public Health Alliance

Catch up on EPHA’s other #A2MDialogues below

Sustainable access to effective antibiotics - what should the EU do?

15 April 2021

After COVID-19, what's next for EU medicines policies?

9 March 2021

Getting it right: Recommendations for a European BARDA

8 December 2020

The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

Pharma & COVID19: Winners, losers, prospects

19 November  2020

The EU's IP strategy: Enabler or barrier?

27 October 2020

Unleashing meaningful innovation through regulatory reform

19 October 2020

Follow on social media




Yannis Natsis

Policy Manager, Universal Access and Affordable Medicines, EPHA

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!